Cesare Gridelli

19.4k total citations · 4 hit papers
413 papers, 12.6k citations indexed

About

Cesare Gridelli is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Cesare Gridelli has authored 413 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 326 papers in Pulmonary and Respiratory Medicine, 313 papers in Oncology and 77 papers in Molecular Biology. Recurrent topics in Cesare Gridelli's work include Lung Cancer Treatments and Mutations (304 papers), Lung Cancer Research Studies (199 papers) and Lung Cancer Diagnosis and Treatment (128 papers). Cesare Gridelli is often cited by papers focused on Lung Cancer Treatments and Mutations (304 papers), Lung Cancer Research Studies (199 papers) and Lung Cancer Diagnosis and Treatment (128 papers). Cesare Gridelli collaborates with scholars based in Italy, United States and Spain. Cesare Gridelli's co-authors include Antônio Rossi, Paolo Maione, Massimo Di Maïo, Enriqueta Felip, Fortunato Ciardiello, Filippo de Marinis, Solange Peters, Ciro Gallo, Francesco Perrone and Alex A. Adjei and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Cesare Gridelli

407 papers receiving 12.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2012 791 citations Cesare Gridelli, Enriqueta Felip et al. Annals of Oncology profile →
Non-small-cell lung cancer

2015 752 citations Cesare Gridelli, Antônio Rossi et al. profile →
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

2017 412 citations Lucio Crinò, Cesare Gridelli et al. profile →
Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials

2015 330 citations Massimo Di Maïo, Ciro Gallo et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cesare Gridelli Italy	55	7.7k	7.3k	3.1k	1.7k	1.2k	413	12.6k
Katsuyuki Kiura Japan	54	7.6k 1.0×	8.2k 1.1×	3.9k 1.2×	1.9k 1.1×	818 0.7×	578	12.5k
Nasser H. Hanna United States	50	7.0k 0.9×	7.1k 1.0×	2.7k 0.9×	1.1k 0.7×	1.4k 1.2×	301	11.4k
Tarek Mekhail United States	41	5.8k 0.8×	6.9k 0.9×	3.0k 1.0×	1.8k 1.1×	753 0.6×	170	10.6k
Nobuyuki Yamamoto Japan	58	11.6k 1.5×	12.5k 1.7×	4.0k 1.3×	2.5k 1.5×	1.2k 1.1×	574	17.3k
Maciej Krzakowski Poland	43	7.6k 1.0×	6.4k 0.9×	2.2k 0.7×	1.6k 0.9×	944 0.8×	261	11.4k
Massimo Di Maïo Italy	50	5.1k 0.7×	3.9k 0.5×	2.0k 0.6×	1.4k 0.8×	1.1k 0.9×	403	9.3k
Hedy L. Kindler United States	61	8.4k 1.1×	7.3k 1.0×	3.6k 1.1×	3.1k 1.8×	1.8k 1.6×	400	16.1k
Edward S. Kim United States	52	5.2k 0.7×	5.3k 0.7×	2.9k 0.9×	1.9k 1.1×	691 0.6×	216	9.8k
Olivier Rixe France	44	4.9k 0.6×	5.7k 0.8×	5.3k 1.7×	2.8k 1.6×	927 0.8×	205	11.3k
Shirish M. Gadgeel United States	58	10.1k 1.3×	10.1k 1.4×	4.2k 1.3×	2.7k 1.6×	782 0.7×	411	15.3k

Countries citing papers authored by Cesare Gridelli

Since Specialization

Citations

This map shows the geographic impact of Cesare Gridelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cesare Gridelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cesare Gridelli more than expected).

Fields of papers citing papers by Cesare Gridelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cesare Gridelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cesare Gridelli. The network helps show where Cesare Gridelli may publish in the future.

Co-authorship network of co-authors of Cesare Gridelli

This figure shows the co-authorship network connecting the top 25 collaborators of Cesare Gridelli. A scholar is included among the top collaborators of Cesare Gridelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cesare Gridelli. Cesare Gridelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marinis, Filippo de, Andrea Ardizzoni, Ilaria Attili, et al.. (2025). Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel Meeting. Current Oncology. 32(2). 110–110. 2 indexed citations

Maione, Paolo, Rosario Salvi, & Cesare Gridelli. (2024). The Role of Adjuvant Chemotherapy before Osimertinib in Epidermal Growth Factor Receptor Mutant Resected Non-Small Cell Lung Cancer and Communicating It to Patients. Current Oncology. 31(2). 987–997.

Wu, Yonghui, Rui Fan, Cesare Gridelli, et al.. (2023). A retrospective comparative cohort study: concurrent versus consolidative immunotherapy with chemoradiotherapy in EGFR- or ALK-negative unresectable stage III non-small cell lung cancer. Translational Lung Cancer Research. 12(11). 2209–2218. 2 indexed citations

Martini, Giulia, Emilio Bria, Cesare Gridelli, et al.. (2020). 1808TiP Atezolizumab (ATZ) in combination with carboplatin (Cb) and etoposide (Eto) in the treatment of patients with previously untreated extensive-stage small cell lung cancer (ES-SCLC): A multicenter, phase IIIb, single arm, safety study (MAURIS trial). Annals of Oncology. 31. S1044–S1045. 6 indexed citations

Rocco, Danilo, Luigi Della Gravara, Umberto Malapelle, Giancarlo Troncone, & Cesare Gridelli. (2019). Second-line avelumab in platinum-treated non-small cell lung cancer patients: comment on the JAVELIN Lung 200 clinical trial. Translational Cancer Research. 8(2). 2 indexed citations

Rocco, Danilo, Luigi Della Gravara, & Cesare Gridelli. (2019). The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and Perspectives. Current Clinical Pharmacology. 15(1). 11–19. 15 indexed citations

Ascierto, Paolo A., James Brugarolas, Luigi Buonaguro, et al.. (2018). Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy). Journal for ImmunoTherapy of Cancer. 6(1). 69–69. 9 indexed citations

Pace, Leonardo, Laura Evangelista, Luigi Mansi, et al.. (2018). Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial. European Journal of Nuclear Medicine and Molecular Imaging. 45(11). 1908–1914. 13 indexed citations

Gridelli, Cesare, Paul Baas, Fabrice Barlési, et al.. (2017). Second-Line Treatment Options in Non–Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology. Clinical Lung Cancer. 19(4). 301–314. 8 indexed citations

10.

Maïo, Massimo Di, Ciro Gallo, Natasha B. Leighl, et al.. (2015). Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials. Journal of Clinical Oncology. 33(8). 910–915. 330 indexed citations breakdown →

11.

Scagliotti, Giorgio V., Cesare Gridelli, Filippo de Marinis, et al.. (2014). Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials. Lung Cancer. 85(3). 408–414. 18 indexed citations

12.

Marchetti, Antonio, Andrea Ardizzoni, Mauro Papotti, et al.. (2013). Recommendations for the Analysis of ALK Gene Rearrangements in Non–Small-Cell Lung Cancer: A Consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology. Journal of Thoracic Oncology. 8(3). 352–358. 40 indexed citations

13.

Gridelli, Cesare, Andrea Ardizzoni, Sandro Barni, et al.. (2011). Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational “SUN” (Survey on the lUng cancer maNagement) study. Lung Cancer. 74(3). 462–468. 13 indexed citations

14.

Groen, Henk, James A. Williams, Feng Gao, et al.. (2010). Biomarker Associations With Survival for Refractory NSCLC Patients Receiving Erlotinib +/- Sunitinib in a Randomized Phase 2 Trial. Data Archiving and Networked Services (DANS). 1 indexed citations

15.

Gridelli, Cesare, Andrea Ardizzoni, Jean‐Yves Douillard, et al.. (2009). Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology. Lung Cancer. 68(3). 319–331. 57 indexed citations

16.

Gridelli, Cesare. (2007). The Use of Bisphosphonates in Elderly Cancer Patients. The Oncologist. 12(1). 62–71. 17 indexed citations

17.

Gridelli, Cesare, Ciro Gallo, Massimo Di Maïo, et al.. (2004). A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study. British Journal of Cancer. 91(12). 1996–2004. 143 indexed citations

18.

Rossi, Antônio, Giuseppe Colantuoni, Nicola Cantore, et al.. (2004). Complete response of severe symptomatic bone marrow metastases from heavily pretreated breast cancer with a 3-weekly trastuzumab schedule. A clinical case.. PubMed. 24(1). 317–9. 3 indexed citations

19.

Gridelli, Cesare, et al.. (2002). Oral cytotoxic drugs.. PubMed. 1(4). S19–23. 3 indexed citations

20.

Gridelli, Cesare & John D. Hainsworth. (2002). Meeting the chemotherapy needs of elderly and poor performance status patients with NSCLC. Lung Cancer. 38. 37–41. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact